Cancer BiologybioRxivPreprint
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML
Ilias Sinanidis, Panagiotis Tsakiroglou, Benjamin G. Dubner…·William Brian Dalton
The paper identifies serine auxotrophy in AML as a vulnerability driven by PSAT1 suppression, showing sensitivity to serine/glycine restriction and potential therapeutic targeting.
1 citation